What is NDC 67877-890?

67877-890 is the product NDC for Mirabegron, Mirabegron 8 mg/mL for suspension, extended release, listed with the FDA by Ascend Laboratories, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mirabegron?

16 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mirabegron NDC 67877-890 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-890Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0890Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67877-890-88	67877089088	1 POUCH in 1 CARTON (67877-890-88) / 1 BOTTLE in 1 POUCH / 100 mL in 1 BOTTLEMarketed from Jun 15, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mirabegron
Generic name (nonproprietary): mirabegron
Active ingredients: Mirabegron — 8 mg/mL
Dosage form: For suspension, Extended release
Route: Oral
Labeler: Ascend Laboratories, LLCNDC labeler code 67877
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219323
Marketing start: Jun 15, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta3-Agonists (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 67877-890_bea3fc38-dab4-4a11-b7a1-911b302f6504SPL ID bea3fc38-dab4-4a11-b7a1-911b302f6504SPL set ID 1c9022af-4841-4f3f-9737-1c5eef58e86bRxCUI 2541233UNII MVR3JL3B2V
Pharmacologic class: beta3-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877089088 followed by a unit qualifier and the quantity

Package 67877-0890-88. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 22, 2026.

Indications (excerpt from the label)

Mirabegron for extended-release oral suspension is a beta-3 adrenergic agonist indicated for the treatment of NDO in pediatric patients aged 3 years and older. ( 1.2 ) 1.2 Pediatric Neurogenic Detrusor Overactivity (NDO) Mirabegron for Extended-Release Oral Suspension Mirabegron for extended-release oral suspension is indicated for the treatment of NDO in pediatric patients aged 3 years and older.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67877-890

What is NDC 67877-890?: 67877-890 is the product NDC for Mirabegron, Mirabegron 8 mg/mL for suspension, extended release, listed with the FDA by Ascend Laboratories, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mirabegron.
What is the active ingredient?: Mirabegron.
Who is the labeler?: Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mirabegron?: 16 other product NDCs are listed under this name. See all Mirabegron NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Mirabegron NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Mirabegron	Mirabegron 50 mg/1	Tablet, Film coated, Extended releaseOral	REMEDYREPACK INC.	70518-4665	70518-4665-00
Mirabegron	Mirabegron 25 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4631	70518-4631-00
Mirabegron	Mirabegron 25 mg/1	Tablet, Film coated, Extended releaseOral	Amneal Pharmaceuticals NY LLC	69238-2860	69238-2860-0169238-2860-02
Mirabegron	Mirabegron 50 mg/1	Tablet, Film coated, Extended releaseOral	Amneal Pharmaceuticals NY LLC	69238-2861	69238-2861-0169238-2861-02
Mirabegron	Mirabegron 25 mg/1	Tablet, Film coated, Extended releaseOral	Qilu Pharmaceutical Co., Ltd.	67184-0571	67184-0571-0167184-0571-02
Mirabegron	Mirabegron 50 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4304	70518-4304-00
Mirabegron	Mirabegron 50 mg/1	Tablet, Film coated, Extended releaseOral	Lupin Pharmaceuticals, Inc.	68180-152	68180-0152-0668180-0152-09
Mirabegron	Mirabegron 50 mg/1	Tablet, Film coated, Extended releaseOral	Bryant Ranch Prepack	71335-2808	71335-2808-01
Mirabegron	Mirabegron 50 mg/1	Tablet, Film coated, Extended releaseOral	Bryant Ranch Prepack	71335-2810	71335-2810-01
Mirabegron	Mirabegron 25 mg/1	Tablet, Film coated, Extended releaseOral	Lupin Pharmaceuticals, Inc.	68180-151	68180-0151-0668180-0151-09

All 17 Mirabegron NDCs